What Are The 4 Types Of Dialysis Explained Clearly

Published

Table of Contents

Dialysis serves as a life-sustaining intervention for patients with compromised kidney function, replicating essential physiological processes to maintain homeostasis. When kidneys fail to filter waste, balance electrolytes, or regulate fluid levels, dialysis becomes indispensable, offering a bridge to treatment or transplantation. This process is not merely medical—it is a carefully calibrated system of filtration, diffusion, and fluid management, tailored to individual patient needs. Understanding the four primary modalities—each with distinct mechanisms, applications, and patient impacts—provides clarity for both healthcare professionals and those navigating renal care.

The progression from healthy renal function to end-stage renal disease (ESRD) underscores the urgency of dialysis, whether due to chronic conditions like diabetes or acute injuries such as sepsis. Each modality—hemodialysis, peritoneal dialysis, continuous renal replacement therapy (CRRT), and hybrid approaches—addresses unique clinical scenarios, from outpatient maintenance to critical care stabilization. By examining their operational principles, procedural demands, and physiological effects, we illuminate how these therapies restore balance while adapting to the complexities of kidney failure.

what are the 4 types of dialysis

Fundamentals of Dialysis: Mimicking Kidney Function in Renal Failure

Dialysis serves as a life-sustaining medical intervention for individuals whose kidneys can no longer adequately filter waste, balance electrolytes, or regulate fluid levels. The human kidneys perform critical functions—including filtration of blood, removal of metabolic byproducts (e.g., urea, creatinine), and maintenance of acid-base equilibrium—through a complex network of nephrons. When kidney function declines to less than 10–15% of normal, dialysis becomes essential to prevent systemic toxicity, electrolyte imbalances, and fluid overload. This section explores the physiological basis of dialysis, its mechanistic parallels to natural kidney function, and the clinical conditions necessitating its use.

The core principle of dialysis lies in its ability to replicate the three primary renal functions: ultrafiltration (fluid removal), solute clearance (waste elimination), and electrolyte regulation. While the kidneys achieve this through active transport, hormonal modulation, and selective permeability, dialysis employs artificial membranes and diffusion principles to achieve comparable outcomes. Below is a structured comparison of these functions:

Kidney Function Dialysis Function
  • Filtration: Glomerular filtration rate (GFR) of ~120 mL/min in healthy adults, driven by hydrostatic pressure in the glomerulus.
  • Selective Reabsorption: Tubular reabsorption of essential solutes (e.g., glucose, amino acids) via active transport.
  • Hormonal Regulation: Production of erythropoietin (EPO), renin, and activation of vitamin D.
  • Filtration: Ultrafiltration via transmembrane pressure in hemodialysis (HD) or osmotic gradients in peritoneal dialysis (PD), achieving controlled fluid removal.
  • Diffusion/Clearance: Solute removal through concentration gradients across semipermeable membranes (e.g., urea, potassium, phosphate).
  • Electrolyte Balance: Manual adjustment of dialysate composition to correct imbalances (e.g., sodium, calcium, bicarbonate).
Key Limitation: Kidneys actively regulate acid-base balance via ammonia production and bicarbonate reabsorption, whereas dialysis relies on pre-set dialysate bicarbonate concentrations.
Key Limitation: Dialysis cannot replicate endocrine functions (e.g., EPO production), necessitating supplementary medications (e.g., recombinant EPO for anemia).

Medical Conditions Requiring Dialysis: Physiological Triggers and Progression

Dialysis is indicated in two primary clinical scenarios: end-stage renal disease (ESRD), where kidney function is irreversibly impaired, and acute kidney injury (AKI), where sudden loss of function threatens life. The progression to dialysis depends on the underlying etiology, rate of functional decline, and presence of complications such as uremia (accumulation of nitrogenous waste), hyperkalemia, or pulmonary edema.

Chronic Kidney Disease (CKD) Progression to ESRD:
CKD is classified into five stages based on GFR, with Stage 5 (GFR <15 mL/min/1.73 m²) defining ESRD. Physiological triggers for dialysis initiation include:

  • Uremic Symptoms: Pericarditis, encephalopathy, or severe pruritus due to toxin accumulation.
  • Electrolyte Disturbances: Refractory hyperkalemia (>6.5 mEq/L) or metabolic acidosis (bicarbonate <15 mEq/L).
  • Fluid Overload: Pulmonary edema or hypertension unresponsive to diuretics.
  • Comorbidities: Cardiovascular disease or malnutrition exacerbating renal decline.

    • Acute Kidney Injury (AKI) Indications:
    AKI may necessitate dialysis in cases of:

  • Oliguric/Anuric Phase: Urine output <0.3 mL/kg/h for ≥48 hours with rising creatinine.
  • Toxin Overload: Severe drug intoxication (e.g., lithium, methanol) or rhabdomyolysis (myoglobinuria).
  • Refractory Edema: Volume overload in sepsis or post-cardiac surgery.
  • Metabolic Emergencies: Severe lactic acidosis (pH <7.1) or diabetic ketoacidosis with renal failure.

    • Flowchart: Progression from Healthy Kidneys to Dialysis Dependency

    The transition to dialysis follows a predictable pathophysiological pathway, outlined below:

    1. Healthy Kidneys (GFR ≥90 mL/min):

  • Normal filtration, hormone production, and waste clearance.
  • Trigger: Underlying disease (e.g., diabetes, hypertension, glomerulonephritis).

    • 2. Early CKD (Stages 1–3, GFR 15–89 mL/min):

  • Progressive nephron loss (e.g., diabetic nephropathy, polycystic kidney disease).
  • Physiological Changes: Compensatory hyperfiltration in remaining nephrons; microalbuminuria.

    • 3. Advanced CKD (Stages 4–5, GFR <15 mL/min):

  • Uremic toxin accumulation (e.g., indoxyl sulfate, p-cresol).
  • Clinical Manifestations: Anemia (due to EPO deficiency), bone disease (secondary hyperparathyroidism).

    • 4. ESRD (Stage 5, GFR <10 mL/min):

  • Loss of autonomous regulatory functions; dialysis or transplant required.
  • Dialysis Initiation: Typically when GFR <10 mL/min or symptomatic uremia develops.

    • 5. Dialysis Dependency:

  • Hemodialysis (HD): Three sessions/week via vascular access (AV fistula/graft).
  • Peritoneal Dialysis (PD): Continuous ambulatory PD (CAPD) or automated PD (APD).
  • Alternative: Kidney transplantation if medically eligible.
    • Critical Threshold: The Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend initiating dialysis when GFR <10–15 mL/min or in the presence of irreversible uremic complications, though earlier intervention may occur in symptomatic patients.

    what are the 4 types of dialysis - Ilustrasi 2

    Hemodialysis: Mechanics, Procedures, and Patient Experience

    Hemodialysis is the most common renal replacement therapy for patients with end-stage renal disease (ESRD), accounting for approximately 90% of dialysis treatments worldwide. This modality relies on the principles of diffusion and ultrafiltration to remove waste products, excess fluids, and toxins from the bloodstream, simulating key functions of healthy kidneys. The procedure requires specialized vascular access, precise machine calibration, and close patient monitoring to ensure efficacy and safety. Below, the mechanics of hemodialysis—including vascular access methods, the dialyzer’s role, and the physiological processes of purification—are detailed, alongside a comparative analysis of session frequency, duration, and setup against other dialysis modalities.

    Vascular Access Methods in Hemodialysis

    The efficiency and safety of hemodialysis depend critically on reliable vascular access, which provides a conduit for blood extraction and return. Three primary access types are employed, each with distinct advantages, risks, and suitability based on patient anatomy and clinical status.
    "Optimal vascular access for hemodialysis should be durable, low-risk for infection, and capable of sustaining high blood flow rates (≥300 mL/min)." — Kidney Disease Improving Global Outcomes (KDIGO) Guidelines, 2012
  • Arteriovenous (AV) Fistula: Created surgically by connecting an artery to a vein, typically in the forearm or upper arm. Over time, the vein enlarges (arterialization) to accommodate repeated needle insertions. AV fistulas are the gold standard due to their longevity, low infection risk, and ability to achieve high blood flow rates. Maturation may take 4–12 weeks, requiring preoperative planning and post-operative monitoring.
  • Arteriovenous (AV) Graft: A synthetic conduit (e.g., expanded polytetrafluoroethylene, or ePTFE) surgically placed between an artery and vein. Grafts provide immediate access but carry higher infection and thrombosis risks compared to fistulas. They are often used when fistulas fail to mature or in patients with limited vein availability.
  • Central Venous Catheter (CVC): A temporary access method involving a catheter inserted into a large vein (e.g., jugular, subclavian, or femoral). CVCs are used in acute settings or when other access methods are unavailable. However, they are associated with higher infection rates (e.g., bacteremia) and reduced patient mobility, necessitating strict aseptic techniques and regular assessment for complications.

    • Hemodialysis Procedure: Step-by-Step Overview

    A standard hemodialysis session follows a structured sequence to ensure patient safety and treatment efficacy. The procedure is divided into three phases: pre-dialysis preparation, dialysis treatment, and post-dialysis care. Each phase involves specific equipment, patient interactions, and physiological adjustments.
    "The hemodialysis session must balance ultrafiltration rates to avoid intradialytic hypotension while maintaining adequate solute clearance to prevent uremic toxicity." — National Kidney Foundation (NKF) KDOQI Clinical Practice Guidelines, 2021
    1. Pre-Dialysis Preparation:
  • Vascular Access Assessment: The dialysis nurse or technician verifies patency of the access site (fistula/graft) via auscultation (bruit) and palpation (thrill). For catheters, sterile dressing changes and site inspection for signs of infection (e.g., erythema, purulence) are performed.
  • Weight and Vital Signs: Pre-dialysis weight determines fluid removal targets, while blood pressure, heart rate, and temperature are recorded to establish a baseline.
  • Needle Insertion: Two needles are inserted into the access—one for arterial blood withdrawal (larger bore, typically 15–16 gauge) and one for venous blood return (smaller bore, 16–17 gauge). The arterial needle is positioned upstream to maintain laminar flow and minimize recirculation.

    • 2. Dialysis Treatment:

  • Blood Pump Activation: The hemodialysis machine’s roller or peristaltic pump draws blood at controlled rates (typically 200–400 mL/min), regulated by the machine’s blood flow sensor to prevent air embolism or excessive negative pressure.
  • Dialyzer Interaction: Blood enters the dialyzer (artificial kidney), a hollow-fiber cartridge containing thousands of semipermeable fibers. The dialyzer’s fiber membrane (e.g., cellulose or synthetic polymers) separates blood from the dialysate solution, enabling solute removal via diffusion and fluid removal via ultrafiltration.
  • Diffusion Process: Solutes (e.g., urea, creatinine, potassium) move from the blood (high concentration) to the dialysate (low concentration) through the membrane, driven by concentration gradients. The dialysate composition is tailored to mimic plasma without electrolytes, adjusted based on patient lab values.
  • Ultrafiltration Process: Excess fluid is removed by applying a transmembrane pressure gradient (positive pressure in the dialysate compartment or negative pressure in the blood compartment), forcing water and small solutes across the membrane into the ultrafiltrate bag. Fluid removal rates are monitored via the machine’s ultrafiltration controller to prevent hypotension.
  • Air Detection and Safety: The machine includes air detectors in the blood and dialysate lines to halt the pump if air is detected, preventing air embolism. Pressure alarms monitor for clotting (e.g., due to low blood flow or needle dislodgment).

    • 3. Post-Dialysis Care:

  • Needle Removal and Compression: After the session, needles are removed, and the access site is compressed for 5–10 minutes to prevent bleeding. For fistulas/grafts, a tourniquet or pressure bandage may be applied.
  • Vital Signs and Symptom Assessment: Post-dialysis weight confirms fluid removal, while blood pressure, heart rate, and symptoms (e.g., cramps, nausea, dizziness) are reassessed. Intradialytic hypotension (systolic BP < 90 mmHg or ≥20 mmHg drop) may require adjustments to ultrafiltration rates or sodium modeling in subsequent sessions.
  • Equipment Disposal and Documentation: Used needles, dialyzers, and tubing are disposed of in biohazard containers. Patient records are updated with session details (e.g., blood flow rates, ultrafiltration volume, complications).

    • Comparison of Hemodialysis with Other Dialysis Modalities

    Hemodialysis is characterized by its in-center, high-efficiency approach, contrasting with peritoneal dialysis (PD) and home-based modalities. Below is a comparative analysis of session frequency, duration, and setup:
    "The standard hemodialysis prescription (3x/week, 3–5 hours) is based on achieving a weekly Kt/V (urea clearance) ≥2.1 and ultrafiltration targets tailored to dry weight." — Fouque et al., 2008 (HEMO Study Group)
    ParameterHemodialysis (In-Center)Peritoneal Dialysis (PD)Home HemodialysisHybrid Modalities (e.g., Short Daily HD)
    Session Frequency3x/week (traditional)Daily (continuous ambulatory PD, CAPD) or nocturnal (automated PD, APD)5–7x/week (prolonged or frequent)5–6x/week (e.g., nocturnal HD)
    Session Duration3–5 hours per session4–6 hours (CAPD) or 8–12 hours (APD)2–8 hours per session1.5–3 hours (frequent) or overnight (nocturnal)
    Primary LocationDialysis centerPatient’s homePatient’s homeDialysis center or home
    Vascular AccessAV fistula/graft/catheterTenckhoff catheter (peritoneal)AV fistula/graftAV fistula/graft/catheter
    Equipment DependencyMachine-operated, trained staffCyclers (APD) or manual exchanges (CAPD)Portable machines (e.g., NxStage)Machine-operated, staff-assisted
    Ultrafiltration ControlMachine-regulatedOsmotic gradient (glucose-based)Machine-regulatedMachine-regulated
    Patient AutonomyLow (staff-dependent)High (self-care required)High (training required)Moderate (staff-assisted)
    Infection RiskAccess-related (e.g., CVC sepsis)Peritonitis (1–2 episodes/year)Access-related or machine-relatedAccess-related
    Cost ConsiderationsHigh (center

    Peritoneal Dialysis: Techniques, Equipment, and Daily Routine

    Peritoneal dialysis (PD) represents a home-based renal replacement therapy that leverages the peritoneal membrane as a semi-permeable barrier to remove waste, excess fluids, and toxins from the bloodstream. Unlike hemodialysis, which relies on an external machine, PD utilizes the patient’s abdominal cavity, offering greater flexibility in treatment schedules and lifestyle integration. This method is particularly suited for individuals requiring continuous therapy, though its efficacy depends on proper technique, catheter maintenance, and adherence to sterile protocols. The two primary modalities—Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD)—differ in automation, exchange frequency, and patient involvement, each with distinct advantages in managing fluid and solute balance.

    The peritoneal membrane, comprising the parietal peritoneum (lining the abdominal wall) and visceral peritoneum (covering abdominal organs), functions as a natural filter through passive and active transport mechanisms. Its large surface area (~1.5–2 m²) and rich vascularization facilitate diffusion of solutes (urea, creatinine) and ultrafiltration of excess fluids via osmotic gradients created by dialysate solutions. The membrane’s integrity and permeability are critical; fibrosis or scarring from chronic inflammation can impair its function, necessitating careful monitoring of ultrafiltration rates and solute clearance.

    Types of Peritoneal Dialysis: Operational Differences

    Peritoneal dialysis is categorized into two primary modalities based on exchange frequency, automation, and patient independence. The choice between Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) depends on patient lifestyle, residual renal function, and clinical goals.

    - Continuous Ambulatory Peritoneal Dialysis (CAPD)
    CAPD involves manual exchanges performed 4–5 times daily, with each exchange consisting of a dwell time of 4–8 hours. Patients manually fill the peritoneal cavity with dialysate using a sterile bag system, allow dwell time for solute and fluid equilibrium, then drain the spent solution into a disposal bag. The process is continuous, requiring minimal disruption to daily activities, though it demands strict adherence to aseptic techniques. CAPD is ideal for patients with stable fluid and electrolyte balance who prefer a non-machine-dependent approach.

    - Automated Peritoneal Dialysis (APD)
    APD utilizes a cycler machine to automate exchanges overnight (typically 8–12 hours), with 3–5 cycles per session. Dwell times vary (e.g., 1.5–3 hours per cycle), allowing for shorter daytime dwell periods or a "dry day" (no daytime exchanges). APD offers greater flexibility for patients with active lifestyles, as daytime exchanges may be reduced or eliminated. However, it requires access to electricity and regular machine maintenance. Variants include:

  • Continuous Cyclic Peritoneal Dialysis (CCPD): 4–5 exchanges overnight + a daytime dwell.
  • Tidal Peritoneal Dialysis: Partial drainage during each cycle to minimize residual volume and improve clearance.

    • Operational Comparison:

    CAPD emphasizes manual dexterity and continuous therapy, while APD prioritizes automation and nocturnal efficiency, with both modalities targeting equivalent solute clearance when optimized.

    Anatomy and Function of the Peritoneal Membrane

    The peritoneal membrane serves as the biological filter in PD, consisting of three layers:
    1. Mesothelial cells (single-layered epithelium) lining the abdominal cavity.
    2. Interstitial tissue containing microvasculature and lymphatic vessels.
    3. Capillary endothelium of the peritoneal capillaries, where solute and fluid exchange occurs.

    Mechanisms of Transport:

  • Diffusion: Solutes (urea, creatinine, phosphate) move from blood to dialysate via concentration gradients across the membrane.
  • Ultrafiltration: Excess fluid is drawn into the dialysate via osmotic gradients created by glucose-based osmotic agents (e.g., dextrose), with higher concentrations (e.g., 4.25% glucose) inducing greater ultrafiltration.
  • Convection: Bulk flow of fluid drags solutes through membrane pores, enhancing clearance of middle molecules (e.g., β2-microglobulin).

    • Limitations and Considerations:

  • Peritoneal Transport Status: Patients are classified based on membrane permeability (fast, average, slow transporters), influencing dialysate dwell times and glucose requirements.
  • Fibrosis and Angiogenesis: Chronic inflammation or high glucose exposure can thicken the membrane, reducing efficiency and increasing infection risks.
  • Residual Renal Function (RRF): Preserved kidney function complements PD by removing uremic toxins and reducing dialysate glucose load.
    • The peritoneal membrane’s efficiency declines over time, with ultrafiltration capacity often decreasing by 5–10% annually, necessitating adjustments in dialysate composition or modality switching.

    Step-by-Step Guide to Performing a Peritoneal Dialysis Exchange

    Proper execution of a PD exchange is critical to prevent infections (e.g., peritonitis) and ensure therapeutic efficacy. Below is a sterile, aseptic protocol for a manual exchange (CAPD), applicable to both inflow and outflow phases.

    Preparation:

  • Hand Hygiene: Wash hands with chlorhexidine-based soap for ≥30 seconds; use sterile gloves.
  • Work Area: Use a clean, dry surface (e.g., bed tray) and assemble supplies:
  • Fresh dialysate bag (correct glucose concentration).
  • Empty drainage bag with spike.
  • Sterile transfer set (Y-set or straight set).
  • Catheter clamp and gauze.
  • Antiseptic solution (e.g., 70% isopropyl alcohol or povidone-iodine).
  • Pain medication (if prescribed for catheter access).

    • Catheter Care:

  • Clean Exit Site: Swab the catheter exit site with antiseptic in a circular motion from center outward; allow to dry.
  • Don Gloves: Change gloves if contaminated during cleaning.

    • Inflow Phase (Filling the Peritoneum):

  • Spike the Dialysate Bag: Insert the spike into the dialysate port; squeeze the bag to expel air.
  • Connect Transfer Set: Attach the transfer set to the dialysate bag and catheter (if using a Y-set, clamp the catheter first).
  • Prime the Line: Open the clamp to fill the transfer set, ensuring no air bubbles enter the catheter.
  • Instill Dialysate: Slowly open the catheter clamp to allow fluid inflow; monitor for pain or resistance (may indicate catheter obstruction).
  • Disconnect and Secure: Once empty, disconnect the transfer set, clamp the catheter, and secure the empty bag to the belt.

    • Dwell Phase:

  • Positioning: Encourage the patient to change positions (e.g., lying down, standing) to distribute dialysate evenly.
  • Monitoring: Assess for abdominal discomfort, fever, or cloudy drainage (signs of peritonitis).

    • Outflow Phase (Draining Spent Dialysate):

  • Reconnect Transfer Set: Attach the empty drainage bag to the catheter; ensure the spike is sterile.
  • Unclamp and Drain: Open the catheter clamp to allow fluid outflow; tilt the patient to facilitate drainage if needed.
  • Measure Volume: Record the drainage volume (should match inflow ±200 mL; discrepancies may indicate ultrafiltration failure).
  • Disposal: Seal the spent bag, dispose of supplies, and wash hands again.

    • Post-Exchange Care:

  • Catheter Exit Site: Apply a sterile gauze dressing if oozing is present; secure with tape.
  • Solution Warming: Dialysate should be body-temperature (37°C) to prevent discomfort; pre-warming bags or using a warming cabinet is recommended.
  • Documentation: Log inflow/outflow volumes, glucose concentration, and any adverse events.
    • Critical Aseptic Techniques:
  • Avoid touching the catheter tip or transfer set ports to prevent contamination.
  • Use sterile, single-use supplies for each exchange.
  • Never reuse dialysate bags or transfer sets.

    • Lifestyle Impact: Peritoneal Dialysis vs. Hemodialysis

    The choice between PD and hemodialysis (HD) significantly influences daily routines, dietary restrictions, and travel flexibility. Below is a comparative analysis of key lifestyle factors:
    <

    what are the 4 types of dialysis - Ilustrasi 3

    Specialized Dialysis Modalities: CRRT and Hybrid Approaches

    Continuous Renal Replacement Therapy (CRRT) and hybrid dialysis techniques represent advanced interventions tailored for critically ill patients with acute kidney injury (AKI) or multi-organ failure. Unlike traditional intermittent hemodialysis, these modalities prioritize hemodynamic stability, gradual solute removal, and metabolic equilibrium, making them indispensable in intensive care units (ICUs). CRRT’s continuous operation aligns with the physiological needs of unstable patients, while hybrid approaches (e.g., Sustained Low-Efficiency Dialysis, SLED) bridge the gap between intermittent and continuous therapies. The selection of modality depends on patient-specific factors such as hemodynamic status, volume overload, and metabolic derangements, with each technique offering distinct advantages in solute clearance, ultrafiltration control, and anticoagulation strategies.

    CRRT’s primary role lies in managing AKI in patients with sepsis, shock, or severe fluid overload, where intermittent dialysis may exacerbate hemodynamic instability. The therapy’s gentle, continuous nature minimizes intradialytic hypotension and allows for precise fluid and electrolyte management. Below, the technical principles, clinical applications, and operational mechanics of CRRT and hybrid modalities are detailed, including patient selection criteria to optimize therapeutic outcomes.

    Continuous Renal Replacement Therapy (CRRT): Principles and Indications

    CRRT is designed for patients with acute kidney injury (AKI) complicated by hemodynamic instability, severe volume overload, or metabolic disturbances unresponsive to medical management. Its indications include:
  • Sepsis-associated AKI (vasoplegic shock, capillary leak syndrome).
  • Multi-organ failure (e.g., acute respiratory distress syndrome [ARDS], liver failure with hepatic encephalopathy).
  • Refractory hyperkalemia or metabolic acidosis despite medical therapy.
  • Severe fluid overload (>10% body weight gain) with pulmonary or peripheral edema.
  • Neurocritical care patients (e.g., subarachnoid hemorrhage, traumatic brain injury) where rapid solute shifts may exacerbate intracranial pressure.

    • Unlike intermittent hemodialysis, CRRT operates continuously (24–72 hours) with slower blood flow rates (80–150 mL/min) and ultrafiltration volumes (1–3 L/h), reducing the risk of hypotension. Clearance rates are lower than in intermittent hemodialysis but sufficient for gradual correction of uremia, electrolyte imbalances, and fluid overload. The therapy’s gentle convective and diffusive mechanisms make it suitable for patients with low cardiac output, vasopressor dependence, or coagulopathy, where abrupt solute removal could trigger cardiac or cerebral ischemia.

    CRRT Modes: Mechanisms and Clinical Applications

    CRRT employs three primary modes, each leveraging convection, diffusion, or a combination to achieve solute clearance. The choice of mode depends on the patient’s clinical status, desired ultrafiltration rate, and metabolic goals.
    Convection: Solute removal driven by bulk fluid movement across a semipermeable membrane (ultrafiltration).
    Diffusion: Solute removal via concentration gradients (similar to hemodialysis).
    Combined Modalities: Integration of convection and diffusion for enhanced clearance of both small and middle molecules.
    The following table summarizes the key CRRT modalities, their primary mechanisms, and clinical use cases:
    Factor Hemodialysis Peritoneal Dialysis
    Treatment Location Center-based (3x/week, 3–5 hours/session). Requires travel to dialysis unit. Home-based or work-based. Exchanges performed 4–5x daily (CAPD) or overnight (APD).
    Dietary Restrictions
    Mode Primary Mechanism Clinical Use Cases
    Continuous Venovenous Hemofiltration (CVVH) Pure convection (ultrafiltration-driven solute removal). Requires replacement fluid to maintain hemodynamic stability.
    • Severe volume overload with oliguric AKI.
    • Patients with coagulopathy (minimal blood-membrane contact).
    • Removal of middle molecules (e.g., cytokines, myoglobin).
    Slow Continuous Ultrafiltration (SCUF) Ultrafiltration only (no dialysis or hemofiltration). Fluid removal without solute clearance.
    • Isolated volume overload in hemodynamically unstable patients.
    • Pre-dialysis fluid management in patients awaiting intermittent therapy.
    Continuous Venovenous Hemodiafiltration (CVVHDF) Combined convection (pre-dilution or post-dilution hemofiltration) and diffusion (dialysate bath).
    • Sepsis with metabolic acidosis or hyperkalemia.
    • Removal of both small solutes (urea, creatinine) and middle molecules (β2-microglobulin).
    • Patients requiring aggressive solute control without hemodynamic compromise.
    Continuous Venovenous Dialysis (CVD) Pure diffusion (similar to intermittent hemodialysis but continuous).
    • Metabolic disturbances (e.g., severe hyperkalemia, uremic encephalopathy) in stable patients.
    • Rarely used alone due to limited middle molecule clearance.
    Post-dilution vs. Pre-dilution Hemofiltration:
  • Post-dilution: Replacement fluid is added after blood passes through the hemofilter, increasing solute concentration and clearance efficiency but risking hemoconcentration and clotting.
  • Pre-dilution: Replacement fluid is mixed with blood before the filter, reducing solute concentration but improving hemodynamic tolerance and filter lifespan.

    • Hybrid Dialysis Techniques: SLED and Combined Modalities

    Hybrid approaches integrate elements of intermittent hemodialysis and CRRT to optimize solute clearance while mitigating hemodynamic risks. These techniques are particularly valuable in ICU settings where patients require renal support but cannot tolerate continuous therapy or have fluctuating hemodynamic status.
    Sustained Low-Efficiency Dialysis (SLED):
    A prolonged (6–12 hours) session of hemodialysis with reduced blood flow rates (100–200 mL/min) and ultrafiltration volumes (200–500 mL/h). Mimics CRRT’s gradual solute removal but operates intermittently, reducing nursing burden and resource utilization.
    Advantages of Hybrid Modalities:
  • Hemodynamic Stability: Slower blood flow and ultrafiltration rates minimize intradialytic hypotension.
  • Flexibility: Can be adjusted based on patient response (e.g., switching to CRRT if hypotension occurs).
  • Resource Efficiency: Requires less ICU monitoring than CRRT, allowing for step-down care.
  • Middle Molecule Clearance: Combined hemofiltration-dialysis (e.g., SLED with hemofiltration) enhances removal of inflammatory mediators (e.g., cytokines, interleukin-6).

    • Clinical Applications:

  • Sepsis with AKI: SLED reduces pro-inflammatory cytokine levels while maintaining hemodynamic stability.
  • Post-cardiac Surgery AKI: Gradual ultrafiltration prevents volume overload without triggering hypotension.
  • Transition from CRRT to Intermittent Dialysis: Hybrid modalities facilitate weaning from CRRT in stable patients.

    • CRRT Machine Functionality and Operational Parameters

    CRRT machines integrate blood circuit management, ultrafiltration control, and anticoagulation to ensure safe and effective therapy. Key components include:
    1. Blood Circuit and Hemofilter:
    2. Double-lumen catheter (e.g., 11–15 Fr) inserted into the femoral, jugular, or subclavian vein for venous access.
    3. Hemofilter (polyacrylonitrile, polysulfone, or cellulose-based) with a surface area of 0.5–2.5 m², selected based on patient size and clearance needs.
      4. Filter Lifespan: Typically 24–72 hours; shorter in patients with coagulopathy or high ultrafiltration rates.
    4. Replacement Fluid Systems:
    5. Balanced crystalloid solutions (e.g., Plasma-Lyte, Normal Saline) are infused to replace ultrafiltrate and maintain hemodynamic stability.
    6. Pre-dilution vs. Post-dilution: Affects solute clearance efficiency and filter clotting risk.
    7. Ultrafiltration Control:
    8. Weight-based targets: Ultrafiltration rates are adjusted to achieve 20–30 mL/kg/day in oliguric patients or 1–2 L/h in anuric patients.
    9. Dynamic adjustment: Real-time monitoring of central venous

      From the precision of hemodialysis’s artificial filtration to the continuous support of CRRT in intensive care, each dialysis modality reflects a fusion of medical innovation and patient-centered care. Peritoneal dialysis offers autonomy and lifestyle flexibility, while hybrid techniques bridge acute and chronic needs with hemodynamic precision. Together, these methods not only extend survival but also improve quality of life, demonstrating the adaptability of renal replacement therapy. As advancements continue, the choice of modality remains a critical decision—one that balances clinical necessity with individual well-being, ensuring patients receive the most appropriate care at every stage of kidney disease.

      10. FAQ

      what are the 4 types of dialysis hindi?

      Q: What are the four main types of dialysis mentioned in Hindi medical resources?

      what are the 4 types of kidney disease?

      Q: What are the four types of kidney disease?

      what are the 4 types of kidney cancer?

      Q: What are the four types of kidney cancer?

      what are the 4 types of kidney stones?

      Q: What are the four types of kidney stones?

      what are the 4 types of peritoneal dialysis?

      Q: What are the four types of peritoneal dialysis?

      what are the different types of dialysis?

      Q: What are the different types of dialysis available for kidney patients?